// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

The Weekend Effect in GUM: A preliminary audit into Genital Herpes management across the week

Emma Machell - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Genital herpes

Acyclovir

A review of the management of rectal chlamydia in three clinics before and during the Covid-19 pandemic

Dawn Friday - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

Doxycycline

An audit of patients prescribed PrEP using telephone appointments in a community sexual health centre during the COVID-19 pandemic

Madryn Riewer - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

Emtricitabine/tenofovir

Lesions mimicking Kaposi sarcoma in a woman living with HIV following Pfizer-BioNTech COVID-19 vaccination

Luke Cannon - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Kaposi's sarcoma

Erythromycin

Screening for latent tuberculosis in a large urban HIV positive population – pilot reveals 11.6% positivity rate

Deborah Kirkham - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

Interferon Gamma

Do women get what they want? A service review of online contraception offered by an NHS integrated sexual health service

Farah Rashid Chawdhary - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Audit of mycoplasma genitalium management: challenges in a London clinic

Harriet Howard - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Increasing tetracycline resistance in Neisseria gonorrhoeae in England: investigating possible clinic-epidemiological associations

Rachel Pitt - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Tetracycline

Improving and implementing new safeguarding pathways during a pandemic

Darlaine Honey - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Increasing human immunodeficiency virus (HIV) testing in a secure setting

Belinda Loftus - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Symptom status and postal kit return rates of individuals accessing an online sexually transmitted infection (STI) testing service

Charlotte Goward - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Testing 7376 samples for Trichomonas vaginalis using NAAT testing in symptomatic females with vaginal discharge and asymptomatic females of all ethnicities through an online STI testing service

Lesley Navaratine - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Our experience of the first patient diagnosed with HIV via routine, opt-out Emergency Department (ED) testing

Rishi Banerjee - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

TOC three ways: An evaluation of methods of test of cure for GC and MG

Elizabeth Hodges - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Three cycle QIP: Improving testing and management of Mycoplasma genitalium in a tertiary sexual health centre 2019 – 2021

Grace Farrington - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Possible case of donovanosis successfully treated with co-amoxiclav

Anura Piyadigamage - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Erythromycin

Time to start testing for latent TB infection(LTBI)- a quality improvement project

Sophie Forsyth - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Who, what, when, where, how and why? Addressing the challenges of Patient and Public Involvement and Engagement (PPIE) within STI research and co-producing and applying a PPIE strategy within the SEQUENCE Digital research programme

Melvina Woode Owusu - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Audit of care of patients with lymphogranuloma venereum (LGV) in a sexual health clinic between 1st January 2019 and 30th September 2021

Jack Jameson - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Doxycycline

‘Sexual and Reproductive Health of International Students in the UK: Access and Inequality’

CG Roesch - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved